Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewGenetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapyRifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trialOrigin and evolution of sulfadoxine resistant Plasmodium falciparumA database of antimalarial drug resistance.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum.Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.Molecular epidemiology of drug-resistant malaria in western Kenya highlands.Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virusDrug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries.Analysis of the dihydrofolate reductase-thymidylate synthase gene sequences in Plasmodium vivax field isolates that failed chloroquine treatment.Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, TanzaniaMolecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.Placental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting.The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New GuineaRapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policyHigh rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in BeninPrevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, AngolaMolecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East.Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, TanzaniaDecreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
P2860
Q21133667-3B8A433B-5366-4368-B090-27B3AAAF33F2Q28125913-B2ABDCA2-A9C0-4BAF-8908-3201919D0AA5Q28469083-7157F753-30A9-4C81-B05A-EF871DCBD82DQ28473479-C6CECB26-88EB-45E1-A973-6E94D3BF3A8CQ30483123-255F079B-3A59-40EC-ABED-5B02B86DAEF6Q30483555-C3F93C80-3F91-4B8B-B257-0E30277530E9Q30541962-31BA3FF8-327C-4443-8B4A-1BDBB5ED8730Q31064063-985D40E3-0B66-4E53-8304-E30EC417CCF2Q33356795-1777F7F0-145C-4057-82FB-134949E9C454Q33645352-B8DB14C1-8A40-4507-A8F0-3E4D9864099EQ33817605-6C0B5976-29F2-4846-A08B-034998AE2B79Q34014169-D59EBE6A-C794-4650-8228-0BBA797F9B93Q34087282-08B3444D-643D-41E4-80E3-D1D6BE02866FQ34393404-832542A4-B832-44A3-A9E8-CBBA18D93036Q34748630-F0B4F730-9A00-429A-9048-9C8481C96AF7Q35129708-C1BA488B-0115-4DB7-AC74-810C319A9CE0Q35171924-C6253261-4113-434B-A498-C0CF585C8A69Q35505497-F9007F23-0241-40F7-9341-D840E2BD6E17Q35541212-EFE92A17-8D0F-4FD1-BB22-15D439F9FFACQ35635957-7718A0F3-41B8-4D2F-ABD2-173C9BF2495BQ35755266-3E4E15F1-F07F-486D-82DD-4154942FB91FQ36391717-68A30DDF-9992-45BD-A9DE-A42BB119DABAQ36649305-CA0E0C58-CAFE-4074-8C14-FE47709EBC78Q36786675-95A167AA-50EC-4057-8420-E1CA2A49558BQ36835042-5921E501-8035-48BB-A872-C5BC6CB6F97AQ36940415-9C8D68F1-EEB0-4F3E-918A-E85E3797FAFBQ37035250-72E293FB-7F8C-4A50-89CE-8152E08EAB3EQ37121527-8D041F9A-5071-47C7-BE9A-51AE2E7164E3Q37121532-981375DA-8983-49AA-B175-8BF6735C1046Q37190605-E52CCCD2-F95B-4381-B7A0-19F50D7C5B22Q37262379-4EA0574A-655F-4D77-924A-B46B7E43C1C0Q37323427-89D682CF-62A3-4CE8-ABAB-1FFECECEA7E5Q37429678-78D83C4E-44CC-46D1-85F6-6ADB860B3F52
P2860
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Validation of a simplified met ...... ldren with falciparum malaria.
@en
type
label
Validation of a simplified met ...... ldren with falciparum malaria.
@en
prefLabel
Validation of a simplified met ...... ldren with falciparum malaria.
@en
P2093
P50
P921
P1476
Validation of a simplified met ...... ildren with falciparum malaria
@en
P2093
Adithya Cattamanchi
Daniel Kyabayinze
Grant Dorsey
Moses R Kamya
Philip J Rosenthal
P304
P407
P577
2003-09-01T00:00:00Z